
Sep 23, 2024, 14:15
Silvia Marchesi: Erythrocytosis in thyroid cancer patients undergoing oral treatment
Silvia Marchesi, Oncology resident at National Institute of Cancer, shared on X:
” Excited to have shared during ESMO 2024 the results of our study on erythrocytosis in thyroid cancer patients undergoing oral treatment.
A huge thank you to my mentors for their support throughout this project Prof Lisa Licitra, Salvatore Alfieri and Prof Laura Locati.”
Source: Silvia Marchesi/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 6, 2025, 03:41
Jun 6, 2025, 01:10
Jun 5, 2025, 15:47
Jun 5, 2025, 15:44